A new target for differentiation therapy in AML.
Cell Res
; 27(1): 9-10, 2017 01.
Article
en En
| MEDLINE
| ID: mdl-27834347
ABSTRACT
Despite major advances in understanding the genetics and epigenetics of acute myelogenous leukemia, there is still a great need to develop more specific and effective therapies. High throughput approaches involving either genetic approaches or small molecule inhibitor screens are beginning to identify promising new therapeutic targets.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Leucemia Mieloide Aguda
Límite:
Humans
Idioma:
En
Revista:
Cell Res
Año:
2017
Tipo del documento:
Article
País de afiliación:
Estados Unidos